Testing a spacing gel to improve prostate cancer freezing treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a special gel placed between the prostate and rectum improves the safety and effectiveness of cryoablation—a freezing treatment for prostate cancer. The gel aims to protect the rectum from cold damage during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 40–95 years
- You have been diagnosed with prostate cancer (Grade Group 2 or higher) confirmed by biopsy
- Your cancer is localized (not spread beyond the prostate) and visible on MRI imaging
- Your PSA level is below 20 ng/ml
- You have no evidence of cancer spreading to other parts of your body
- You are willing and able to have cryoablation under anesthesia and attend follow-up appointments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks outcomes for men who choose cryotherapy (freezing cancer cells) to treat prostate cancer that hasn't spread. It helps doctors understand how well this treatment works.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This trial tests a gel placed in the rectum during radiation therapy to protect healthy tissue after prostate removal. It is for men whose prostate cancer has come back (PSA rise) and who need radiation to the prostate bed.
This trial compares standard hormone therapy (ADT) alone versus ADT plus a procedure that freezes the prostate (cryoablation) in people whose prostate cancer has spread. It looks to see whether adding freezing improves outcomes while keeping treatment safe.
This trial studies a treatment where doctors use MRI pictures to guide freezing of a prostate tumor. It may help men with smaller, well-placed prostate cancers who cannot or do not want surgery or radiation right now.
This trial tests freezing prostate tumors (cryoablation) combined with a low-dose chemotherapy pill (metronomic cyclophosphamide) for men with metastatic prostate cancer. The goal is to see if this combination can slow the cancer's growth and improve outcomes.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.